Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1286.46	-453.11	32.68
Graham Fair Price	-7.83	85.77	93.06
PEG	-1137366.32	-0.49	< 0.005
Price/Book	18.12	2.44	2.07
Price/Cash Flow	-12.02	27.98	31.80
Prices/Earnings	51.46	9.33	6.16
Price/Sales	20.43	2.98	2.47
Price/FCF	-12.02	27.98	31.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	92.75	1.00	0.52
Operating Margin	29.52	0.10	0.08
ROA	-12.40	0.01	0.01
ROE	0.08	0.07	-22.01
ROIC	0.04	0.05	31.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-0.05
Dividends QOQ	0.07	-0.03	-56.01
EBIT QOQ	2.28	0.33	-85.43
EPS QOQ	1429.21	-0.19	-99.99
FCF QOQ	-0.02	0.41	1903.31
Revenue QOQ	0.12	0.03	-76.59
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-207.43	0.00	inf
Days Sales Outstanding (DSO)	114.40	113.83	-0.50
Inventory Turnover	-0.43	0.00	inf
Debt/Capitalization	0.32	0.30	-6.12
Quick Ratio	0.59	0.64	8.59
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	67.77	70.74	4.37
Cash	22.37	32.26	44.20
Capex	-0.27	-0.16	42.54
Free Cash Flow	4.40	6.17	40.12
Revenue	56.57	57.91	2.37
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.59	0.45	-23.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.37	-61.10	1037.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating